Abstract
THE membrane glycoprotein CD4 enhances antigen-mediated activation of T cells restricted by class II molecules of the major histocompatibility complex (MHC)1–3. This positive function has been attributed to the protein tyrosine kinase p56lck (ref. 4), which is noncovalently associated with the cytoplasmic portion of CD45,6, and is activated on CD4 aggregation7. Antigen presentation by MHC class II molecules coaggregates CD4 and the T-cell antigen receptor (TCRαβ–CD3)8. Thus, the mutual specificity of CD4 and TCRαβ for the MHC–antigen complex results in the juxtaposition of p56lck and TCRαβ–CD39–13. In contrast, anti-CD4 antibodies can abrogate antigen-induced14–17, as well as anti-TCR-induced18–20 T-cell activation, indicating that CD4 might also transduce negative signals. The molecular basis for this opposing function remains unclear. Here we show that the CD4–p56lck complex prohibits the induction of activation signals through the TCR–CD3 complex when not specifically included in the signalling process. This negative effect does not require anti-CD4 treatment, indicating that the induction of distinct negative signals is probably not involved. Rather, the results demonstrate that the CD4–p56lck complex provides prerequisite signals for antigen-receptor-induced T-cell growth and thus characterize a molecular mechanism for functional constraints imposed on T-cell activation by the MHC.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Emmrich, F., Lothar, L. & Eichmann, K. Eur. J. Immun. 17, 529–534 (1987).
Owens, T., Fazekas de St Groth, B. & Miller, J. F. A. P. Proc. natn. Acad. Sci. U.S.A. 84, 9209–9213 (1987).
Anderson, P., Blue, M.-L., Morimoto, C. & Schlossman, S. F. J. Immunology 139, 678–682 (1987).
Abraham, N., Miceli, M. C., Parnes, J. R. & Veillette, A. Nature 350, 62–66 (1991).
Veillette, A., Bookman, M. A., Horak, E. M. & Bolen, J. B. Cell 55, 301–308 (1988).
Rudd, E. E., Trevillyan, J. M., Dasgupta, J. D., Wong, L. L. & Schlossman, S. F. Proc. natn. Acad. Sci. U.S.A. 85, 5190–5194 (1988).
Veillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E. & Bolen, J. B. Nature 338, 257–259 (1989).
Kupfer, A., Singer, S. J., Janeway, C. A. Jr & Swain, S. L. Proc. natn. Acad. Sci. U.S.A. 84, 5888–5892 (1987).
Doyle, C. & Strominger, J. L. Nature 330, 256–259 (1987).
Barber, E. K., Dasgupta, J. D., Schlossman, S. F., Trevillyan, J. M. & Rudd, C. E. Proc. natn. Acad. Sci. U.S.A. 86, 3277–3281 (1989).
Chuck, R. S., Cantor, C. R. & Tse, D. B. Proc. natn Acad. Sci. U.S.A. 87, 5021–5025 (1990).
Ledbetter, J. A., Gilliland, L. K. & Schieven, G. L. Sem. Immun. 2, 99–106 (1990).
Burgess, K. E. et al. Eur. J. Immun. 21, 1663–1668 (1991).
Biddison, W. E., Rao, P. E., Talle, M. A., Goldstein, G. & Shaw, S. J. exp. Med. 156, 1065–1076 (1982).
Marrack, P. et al. J. exp. Med. 158, 1077–1091 (1983).
Moldwin, R. L. et al. J. Immun. 139, 657–664 (1987).
Rosoff, P. M., Burakoff, S. J. & Greenstein, J. L. Cell 49, 845–853 (1987).
Bank, I. & Chess, L. J. exp. Med. 162, 1294–1303 (1985).
Wassmer, P., Chan, C., Lögdberg, L. & Shevach, E. M. J. Immun. 135, 2237–2242 (1985).
Newell, M. K., Haughn, L. J., Maroun, C. R. & Julius, M. H. Nature 347, 286–289 (1990).
Cambier, J. C. & Julius, M. H. Scand. J. Immun. 27, 59–71 (1988).
Kubo, R. T. et al. J. Immun. 142, 2736–2742 (1989).
Tomonari, K., Lovering, E. & Spencer, S. Immunogenetics 31, 333–339 (1990).
Leo, O., Foo, M., Sachs, D. M., Samelson, L. M. & Bluestone, J. A. Proc. natn. Acad. Sci. U.S.A. 84, 1374–1377 (1987).
Shaw, A. S. et al. Cell 59, 627–636 (1989).
Turner, J. M. et al. Cell 60, 755–765 (1990).
Mustelin, T., Coggeshall, K. M., Isakov, N. & Altman, A. Science 247, 1584–1587 (1990).
Koretzky, G. A., Picus, J., Thomas, M. L. & Weiss, A. Nature 346, 66–68 (1990).
Teh, H.-S. et al. Nature 349, 241–243 (1991).
Van Oers, N. S. C. et al. Eur. J. Immun. 22, 735–743 (1992).
Horak, I. D. et al. Proc. natn. Acad. Sci. U.S.A. 88, 1996–2000 (1991).
Hatakeyama, M. et al. Science 252, 1523–1528 (1991).
Finkel, T. H. et al. J. Immun. 142, 3006–3012 (1989).
Sleckman, B. P. et al. Nature 328, 351–353 (1987).
Glaichenhaus, N., Shastri, N., Littman, D. R. & Turner, J. M. Cell 64, 511–520 (1991).
Karasuyama, H. & Melchers, F. Eur. J. Immun. 18, 97–104 (1988).
Pierres, A. et al. J. Immun. 132, 2775–2783 (1983).
Bhattacharya, A., Dorf, M. E. & Springer, T. A. J. Immun. 127, 2488–2495 (1981).
Springer, T. A. Monoclonal Antibodies 185–192 (Plenum, New York, 1980).
Ledbetter, J. & Herzenberg, L. Immun. Rev. 47, 63–90 (1979).
Veillette, A. & Fournel, M. Oncogene 5, 1455–1462 (1990).
Ho, S. et al. Gene 77, 51–59 (1989).
Fleury, S. et al. Cell 66, 1037–1049 (1991).
Williams, D. A., Lemischka, I. R., Nathan, D. G. & Mulligan, R. C. Nature 310, 476–480 (1984).
Morrison, D. K. et al. Cell 58, 649–657 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haughn, L., Gratton, S., Caron, L. et al. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the αβ T-cell receptor. Nature 358, 328–331 (1992). https://doi.org/10.1038/358328a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/358328a0
This article is cited by
-
Timing and duration of MHC I positive selection signals are adjusted in the thymus to prevent lineage errors
Nature Immunology (2016)
-
Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice
Nature Reviews Immunology (2008)
-
The L‐selectin (Leu8) molecule is associated with the TcR/CD3 receptor; fluorescence energy transfer measurements on live cells
Immunology & Cell Biology (1994)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.